Johnm Boone News Today

Vancouver, British Columbia--(Newsfile Corp. - November 5, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast

Izotropic Corporation(“ Izotropic” or the “Company”)(CSE:IZO)(CNSX:IZO.CN)(OTC:IZOZF) (FSE:1R3)a Company commercializing “Izoview”, a true 3D, dedicated Breast Computed Tomography (CT) imaging technology for the diagnostic identification of breast cancers, provides updates on the following:   - Izoview, 5thgeneration, enhanced product design for performance improvements, added usability, increasing competitive advantages and target market   - Clinical study and regulatory pathway...

Vancouver, British Columbia--(Newsfile Corp. - June 3, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing "Izoview", a true 3D

Izotropic Technology Founder Appointed Editor-In-Chief of Medical Physics Journal VANCOUVER, BC - TheNewswire – December 31, 2020 – Izotropic Corporation (“Izotropic” or the “Company”) (CSE:IZO) (CNSX:IZO.CN) US (OTC:IZOZF) (FSE:1R3) is pleased to highlight the appointment of Director and Principal Founder of Breast CT Technology, Dr. John M. Boone, as the Editor-In-Chief of the American Association of Physicists in Medicine’s (AAPM) flagship medical journal ‘Medical Physics,�...

Izotropic Corporation: Izotropic Reports High Degree of Confidence After Pre-Submission Meeting with FDA Izotropic Corporation (CSE: Izotropic" or the " Company") announces it has received the finalized meeting minutes from the U.S. Food and Drug Administration (FDA) in connection with the Companys recent pre-submission meeting and the market approval process for its commercial Breast CT Imaging System. Dr. John McGraw, Executive Vice-President of Commercial Operations, stated, "I am pleased t...

Izotropic” or the “ Company“) announces it has received the finalized meeting minutes from the U.S. Food and Drug Administration (FDA) in connection with the Company’s recent pre-submission meeting and the market approval process for its commercial Breast CT Imaging System. Dr. John McGraw, Executive Vice-President of Commercial Operations, stated, “I am pleased to report that the meeting with the FDA was very beneficial for Izotropic and the comments received have validated our clini...

Izotropic Reports High Degree of Confidence after Pre-Submission Meeting with FDA   VANCOUVER, BC - TheNewswire - December 15, 2020 - Izotropic Corporation ("Izotropic" or the "Company") (CSE:IZO) (CNSX:IZO.CN) (OTC:IZOZF) (FSE:1R3) announces it has received the finalized meeting minutes from the U.S. Food and Drug Administration (FDA) in connection with the Companys recent pre-submission meeting and the market approval process for its commercial Breast CT Imaging System.   Dr. John McGraw, E...